Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Revenues Up Again; Earnings Also Improve in Q2

NEW YORK, July 21 (GenomeWeb News) - Invitrogen's revenues and earnings increased for the second quarter, the company reported today.

 

Revenues increased approximately 32 percent to $254 million, as compared to $192.4 million reported for the second quarter of 2003.

 

Invitrogen said that the revenue growth included a 19 percent increase in its BioDiscovery unit, due principally to its Molecular Probes acquisition. It also attributed a 53 percent increase in revenues for its BioProduction products to its acquisition of BioReliance and solid customer demand for its cell culture products.

 

Net income for the second quarter also increased, to $19.7 million, from $16.9 million for Q2 of 2003.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.